During the past decade, VA Loma Linda Healthcare System conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 27 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Loma Linda Healthcare System" #1 sponsor was "VA Office of Research and Development" with 23 trials, followed by "US Department of Veterans Affairs" with 11 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "National Cancer Institute (NCI)" with 6 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Loma Linda Healthcare System" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "AIDS Clinical Trials Group" with 2 trials as a collaborator and "Brigham and Women's Hospital" with 2 trials as a collaborator. Other collaborators include 84 different institutions and companies that were collaborators in the rest 79 trials.

According to Clinical.Site data, the most researched conditions in "VA Loma Linda Healthcare System" are "Heart Failure" (7 trials), "Colorectal Cancer" (5 trials), "Atrial Fibrillation" (3 trials), "Healthy" (3 trials) and "Altitude" (2 trials). Many other conditions were trialed in "VA Loma Linda Healthcare System" in a lesser frequency.

Most popular intervention types in "VA Loma Linda Healthcare System" are "Drug" (48 trials), "Other" (17 trials), "Device" (16 trials), "Procedure" (15 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Biospecimen Collection" (4 trials), "Quality-of-Life Assessment" (3 trials), "Gemcitabine" (2 trials) and "Laboratory Biomarker Analysis" (2 trials). Other intervention names were less common.

The vast majority of trials in "VA Loma Linda Healthcare System" are 89 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "VA Loma Linda Healthcare System". undefined are not yet recruiting, 17 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 54 completed trials in VA Loma Linda Healthcare System, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in VA Loma Linda Healthcare System, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 20 trials that are defined as “Not Applicable".